Vident Investment Advisory’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-31,711
| Closed | -$14.1M | – | 325 |
|
|
2023
Q2 | $14.1M | Sell |
31,711
-3,292
| -9% | -$1.52M | 0.49% | 42 |
|
|
2023
Q1 | $16.1M | Buy |
35,003
+2,227
| +7% | +$1.06M | 0.52% | 33 |
|
|
2022
Q4 | $16.8M | Sell |
32,776
-57
| -0.2% | -$28.9K | 0.63% | 26 |
|
|
2022
Q3 | $14.5M | Sell |
32,833
-2,281
| -6% | -$1.09M | 0.47% | 48 |
|
|
2022
Q2 | $16.9M | Buy |
35,114
+358
| +1% | +$177K | 0.51% | 42 |
|
|
2022
Q1 | $17.1M | Buy |
34,756
+3,432
| +11% | +$1.57M | 0.44% | 56 |
|
|
2021
Q4 | $14.5M | Buy |
31,324
+1,189
| +4% | +$500K | 0.38% | 60 |
|
|
2021
Q3 | $11.2M | Buy |
30,135
+19,269
| +177% | +$7.32M | 0.34% | 62 |
|
|
2021
Q2 | $4.15M | Sell |
10,866
-9,774
| -47% | -$3.74M | 0.13% | 162 |
|
|
2021
Q1 | $7.41M | Buy |
20,640
+3,267
| +19% | +$1.05M | 0.25% | 71 |
|
|
2020
Q4 | $5.58M | Buy |
17,373
+1,780
| +11% | +$546K | 0.23% | 78 |
|
|
2020
Q3 | $4.19M | Buy |
15,593
+1,748
| +13% | +$470K | 0.21% | 94 |
|
|
2020
Q2 | $3.64M | Buy |
13,845
+470
| +4% | +$125K | 0.19% | 92 |
|
|
2020
Q1 | $3.04M | Buy |
13,375
+2,854
| +27% | +$778K | 0.2% | 94 |
|
|
2019
Q4 | $3.18M | Buy |
10,521
+8,064
| +328% | +$2.22M | 0.2% | 95 |
|
|
2019
Q3 | $590K | Sell |
2,457
-62
| -2% | -$17K | 0.05% | 283 |
|
|
2019
Q2 | $711K | Sell |
2,519
-9,363
| -79% | -$2.56M | 0.06% | 228 |
|
|
2019
Q1 | $3.41M | Sell |
11,882
-4,340
| -27% | -$1.26M | 0.18% | 103 |
|
|
2018
Q4 | $4.26M | Buy |
16,222
+144
| +0.9% | +$39.6K | 0.24% | 74 |
|
|
2018
Q3 | $4.41M | Sell |
16,078
-994
| -6% | -$258K | 0.17% | 93 |
|
|
2018
Q2 | $4.06M | Sell |
17,072
-942
| -5% | -$218K | 0.16% | 115 |
|
|
2018
Q1 | $4.08M | Sell |
18,014
-906
| -5% | -$213K | 0.17% | 104 |
|
|
2017
Q4 | $4.26M | Buy |
18,920
+3,052
| +19% | +$650K | 0.19% | 85 |
|
|
2017
Q3 | $3.01M | Sell |
15,868
-1,050
| -6% | -$200K | 0.16% | 138 |
|
|
2017
Q2 | $3.18M | Buy |
16,918
+104
| +0.6% | +$18.7K | 0.26% | 77 |
|
|
2017
Q1 | $2.78M | Sell |
16,814
-1,895
| -10% | -$301K | 0.28% | 90 |
|
|
2016
Q4 | $2.69M | Buy |
18,709
+1,406
| +8% | +$188K | 0.33% | 111 |
|
|
2016
Q3 | $2.17M | Buy |
17,303
+793
| +5% | +$102K | 0.29% | 185 |
|
|
2016
Q2 | $2.17M | Sell |
16,510
-16,234
| -50% | -$2.22M | 0.3% | 156 |
|
|
2016
Q1 | $4.55K | Buy |
32,744
+16,403
| +100% | +$2.19M | 0.28% | 137 |
|
|
2015
Q4 | $2.28M | Buy |
16,341
+10,816
| +196% | +$1.49M | 0.29% | 60 |
|
|
2015
Q3 | $774K | Sell |
5,525
-113
| -2% | -$17K | 0.11% | 282 |
|
|
2015
Q2 | $925K | Buy |
5,638
+389
| +7% | +$62.2K | 0.12% | 219 |
|
|
2015
Q1 | $810K | Sell |
5,249
-228
| -4% | -$32.5K | 0.16% | 163 |
|
|
2014
Q4 | $688K | Buy |
+5,477
| New | +$677K | 0.23% | 114 |
|
Other funds holding ELV
